ABSTRACT: Hereford × Angus cows (n = 36; initial wt 568 ± 59 kg) were used to evaluate the effects of undegradable intake protein (UIP) supplementation on plasma hormone and metabolite concentrations. Treatments were control (unsupplemented) or one of three protein supplements. Supplements were fed at 1.3 kg DM/d and included UIP at low, medium, or high levels (53, 223, or 412 g UIP/kg supplement DM, respectively). Supplements were formulated to be isocaloric (1.77 Mcal NE m /kg) and to contain equal amounts of degradable intake protein (DIP; 211 g DIP/kg supplement DM). Prairie hay (5.8% CP) was offered for ad libitum consumption. Jugular blood samples were collected daily from each cow during six 7-d collection periods (corresponding to mo 7, 8, and 9 of gestation and to mo 1, 2, and 3 of lactation). Plasma glucose concentrations were similar between control and supplemented cows during mo 2 and 3 of lactation; however, the low UIP treatment group had consistently higher plasma glucose (P ≤ .02) than cows fed medium or high UIP supple-
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Blood metabolites and hormones are useful indicators of nutritional and physiological status. In ruminants, the range of concentrations over which insulin exerts anabolic effects may be narrow (Lobley, 1992) ; To whom correspondence should be addressed. 4 Present address: Dept. of Anim. Sci., Univ. of Missouri, Columbia 65211.
Received April 14, 1999 . Accepted August 31, 1999 456 ments during gestation and the last month of lactation. During gestation, cows fed the high UIP supplement had higher (P ≤ .08) plasma glucose than cows fed the medium UIP supplement. During gestation, plasma insulin concentration was increased (P = .01) by supplementation; insulin also increased (P < .01; mo 8 and 9) as supplemental UIP increased. During lactation, plasma insulin was greater (P = .01) in supplemented than in control cows. During mo 2 and 3 of lactation, insulin was lower (P ≤ .04) in cows fed low UIP supplement compared with cows fed medium or high UIP supplements. Growth hormone concentration was higher (P ≤ .03) in control cows than in supplemented cows in all periods measured except mo 7 of gestation. Plasma nonesterified fatty acid concentrations were higher (P ≤ .03) in control cows than in supplemented cows in all periods measured except the 1st mo of lactation. These data are interpreted to suggest that protein supplementation and level of UIP can alter plasma concentrations of hormones and metabolites in gestating and lactating beef cows consuming low-quality hay.
however, the protein sparing effects of insulin are not well characterized (Martin, 1985) . Protein supplementation increases insulin concentrations (Krysl et al., 1987; Caton et al., 1988; Cheema et al., 1991) , but insulin concentrations are not always increased by protein supplementation and the level of undegradable intake protein (UIP) in the supplement may influence the response (Caton et al., 1994; Swanson et al., 1999) . Few studies with ruminants have examined blood NEFA concentrations in relation to supplemental protein supply. Caton et al. (1994) reported that supplementing low-quality forage with a blood meal-based UIP source did not affect serum NEFA level. Rusche et al. (1993) observed similar effects of DIP and UIP supplements on plasma NEFA concentration in beef cows. Moreover, others reported that NEFA were higher in unsupplemented controls than in cottonseed meal-supplemented cattle or sheep (Krysl et al., 1987; Cheema et al., 1991; Barton et al., 1992) . Little information is available on plasma hormone and metabolite concentrations in gestating and lactating beef cows in response to increasing level of UIP supplementation, while simultaneously meeting the ruminal DIP requirement. Research in this area should provide insight into the effects of various forms of protein supplementation on plasma hormone and metabolite profiles. Our objectives for the present study were 1) to evaluate the effects of increasing level of UIP supplementation on plasma hormone and metabolite profiles during late gestation and early lactation and 2) to document plasma concentrations of hormones and metabolites in forage-fed beef cows at various times during the periparturient period.
Materials and Methods
Hereford × Angus cows (n = 36; initial BW = 568 ± 59 kg) with projected calving dates between March 10 and May 2, 1993, were used in a split-plot arrangement. After pregnancy was confirmed by rectal palpation during the fall of 1992, cows were stratified by calving date and assigned randomly to one of four treatments: control (no supplement) and low, medium, and high levels of UIP supplement. One cow each from the low and medium treatments refused to train to the electronic gate system and both were removed from the study prior to the beginning of collections. Cows were fed a mature, cool-season grass prairie hay (5.8% CP) harvested in northern Barnes County, North Dakota. Hay was offered daily for ad libitum consumption from October 1992 through May 1993. Supplements, fed daily at 1.3 kg DM, were formulated to contain equal DIP (211 g DIP/kg supplement DM) and energy (1.77 Mcal NE m /kg) and incremental amounts of UIP (53, 223, and 412 g UIP/kg supplement DM, respectively). All cows received an energy-based lactation supplement (2.11 Mcal NE m /kg DM; 1.86 kg DM/d) beginning at parturition and continuing for the remainder of the trial. Ingredient composition of supplements is reported in a companion paper (Sletmoen-Olson et al., 2000) . Low, medium, and high protein supplements were formulated to provide 109, 128, and 151% of NRC (1984) protein requirements. Supplements and diets were evaluated with the beef NRC (1996) model to determine DIP and MP supplies. These data are also reported in the companion paper (Sletmoen-Olson et al., 2000) . According to the NRC (1996) model, cows fed control and low UIP supplements were deficient in metabolizable protein through the study and control cows were deficient in DIP during gestation (Sletmoen-Olson et al., 1999) . Chemical composition of forage and supplements is reported by Sletmoen-Olson et al. (2000) .
Supplement feeding commenced during October 1992 and continued through May 1993. Cows were housed indoors at the Small Animal Research Center at North Dakota State University from October 1992 through May 1993. Cows were given an injection of vitamins A, D, and E (1,500,000, 225,000, and 15 IU, respectively) in October and February. Fresh water and trace-mineralized salt (97% NaCl, .35% Zn, .20% Fe, .18% Mn, .035% Cu, .01% I, and .006% Co) were available to cows continuously during the trial. All animals were handled in accordance with institutional animal care and use guidelines (Consortium, 1988) .
Six 7-d collection periods (PD) were conducted: three during the final 100 d of gestation and three during the first 75 d of lactation. The first three collection periods approximated mo 7, 8, and 9 of gestation and were held during December 5 to 13, January 12 to 20, and February 18 to 26, respectively. The last three collection periods generally corresponded to mo 1, 2, and 3 of lactation and were conducted from March 31 to April 8, April 28 to May 6, and May 21 to 29, respectively. Due to space limitations brought about by calving, 10 cows with later projected calving dates were removed from the confinement facility after completing the third collection period, resulting in six cows per treatment during lactation. No plasma data were collected from removed cows during the lactation phase of the experiment. During each collection period, 10-mL jugular venous blood samples were collected from all cows at 0700 daily, prior to feeding. Blood samples were transferred from collection syringes to EDTA-containing vacuum tubes and placed on ice. Blood was centrifuged immediately following collection at 1,500 × g for 30 min at 4°C. Plasma was decanted and stored at −20°C until it was analyzed for hormones and metabolites.
Plasma samples were allowed to thaw at room temperature before analysis. Plasma glucose was measured using a glucose oxidase kit (Glucose, Procedure No. 510; Sigma Diagnostics, St. Louis, MO). Plasma urea nitrogen was determined using a urease/Berthelot determination (Urea Nitrogen, Procedure No. 640, Sigma Diagnostics). The acyl-CoA synthetase/acyl-CoA oxidase method (NEFA C, Wako Pure Chemical Industries, Dallas, TX) was used to measure plasma NEFA. Plasma GH was measured using a RIA previously validated for bovine plasma (Reynolds et al., 1990) .
Plasma insulin was measured using a commercially available RIA kit (Coat-A-Count, Diagnostic Products, Los Angeles, CA). The assay used guinea pig insulin as the radioiodination preparation, bovine zinc insulin (26.6 IU/mg) in assay buffer as the reference standard (supplied by Lilly Research Laboratories, Indianapolis, IN; units per milligram based on USP rabbit bioassay), and guinea pig antiporcine insulin as the antiserum. Sensitivity of the assay was approximately 1 U/mL, which was the lowest point on the standard curve and displaced 11.8% of the radioligand. Samples were evaluated in two assays, and intra-and interassay variation were determined by assaying replicates of plasma from an ovariectomized (OVX) cow in each case. Within the two assays, the concentrations of insulin in the OVX plasma were 26.19 ± 2.51 U/mL (CV = 9.6%) and 23.84 ± 1.47 U/mL (CV = 6.2%). Across both assays, the concentration of insulin in the OVX plasma pool was 25.01 ± 2.1 U/mL (CV = 8.6%).
To further validate the insulin assay, a fetal and an adult bovine pancreas were each homogenized in five volumes of .15 M NaCl, incubated at 4°C for 1 h, and centrifuged at 700 × g for 30 min. The resulting supernatant fluids were diluted further with assay buffer to yield bovine fetal and maternal pancreatic extracts with final dilutions of 1:35,000 and 1:250, respectively. These pancreatic extracts were assayed at volumes of 25, 50, 100, and 200 L. Human serum containing porcine insulin standards, as provided with the kit, were also assayed. Pancreatic extracts assayed in different volumes and the human serum standards all yielded inhibition curves that were parallel to that of the bovine insulin reference standard. The regression equation for the bovine standard curve was y = 2.51 − 1.47x and for the human serum standards was y = 3.07 − 1.98x, where y = logit of the percentage bound and x = log of insulin concentration in U/mL (r = .99; P < .01). The equation for the adult pancreatic extract was y = 4.07 − 1.53x and for the fetal extract was y = 2.57 − 1.50x (r = .99; P < .01).
Data were analyzed as a split-split-plot arrangement of a completely randomized experiment (Cochran and Cox, 1957; Gilland Hafs, 1971) , using the General Linear Models program for SAS (1985) . Models for plasma insulin, glucose, GH, NEFA, and urea N contained effects for animal, treatment, sampling period, day, animal(treatment), treatment × sampling period, and treatment × sampling period × day. Residual error was used to test for significance of the three-way interaction. The three-way interaction was not significant; therefore, data were compiled across days within animal and sampling period. Models for various hormones and metabolites contained effects for animal, treatment, sampling period, animal(treatment), and treatment × sampling period. Animal(treatment) was used as the error term to test for treatment effects. When treatment × sampling period effects were significant (P < .10), means were separated within period and treatment. Treatment and period sums of squares were partitioned using contrasts when protected by a significant F-test. Treatment means within period were compared using specific contrasts: control vs protein-supplemented treatments, low UIP vs medium and high UIP treatments, and medium UIP vs high UIP treatments. In addition, linear and quadratic contrasts were used to separate period effects within treatment. All means reported in tables are least squares means.
Results and Discussion
Plasma glucose concentrations were higher (P ≤ .03) in low UIP-supplemented cows than in the medium and high UIP-supplemented cows during the majority of the study (gestation and mo 1 of lactation; Table 1 ). Increased plasma glucose concentrations in low UIP cows may have resulted from shifts in ruminal VFA concentrations or increased gluconeogenic precursors provided by the supplement. During gestation, cows fed the medium UIP supplement had lower (P ≤ .08) plasma glucose than the cows fed the high UIP supplement. There seemed to be little association between plasma concentrations of glucose and insulin (Table 2 ). This may have occurred because glucose requirements in ruminant animals are met primarily by gluconeogenic pathways that are not under the direct control of insulin (Collier, 1985) .
In general, plasma glucose levels decreased linearly (P = .01) during the last 100 d of gestation. Approximately 40 to 70% of total glucose metabolism by sheep in late gestation can be accounted for by the fetus (Martin, 1985) . Half of fetal growth occurs during the final 35 d of pregnancy (Baumann and Currie, 1980) ; therefore, the decline in serum glucose with advancing gestation may be related to fetal demand. Glucose concentrations in all treatments increased quadratically (P ≤ .03) during lactation, peaking during mo 2, which corresponds to predicted peak lactation (NRC, 1996) . Control and medium UIP-supplemented cows had greater (P = .01) glucose concentrations during lactation than during gestation, but glucose concentrations were similar during gestation and lactation for low and high UIPsupplemented cows. Demands for glucose during lactation are typically greater than those required during gestation. Glucose is removed from the blood and used by the mammary gland to produce lactose (Larson, 1985) . In high-producing ruminants, lactose production can account for 60 to 85% of total body glucose metabolism (Fahey and Berger, 1988) . Bruckental et al. (1980) estimated that 46 to 57% of glucose in lactating animals was used for synthesis of lactose.
Unsupplemented cows had lower (P = .01) plasma insulin concentrations than supplemented cows during all collection periods measured (Table 2) . Cows fed the low UIP supplement generally had lower (P = .01 to .14) plasma insulin concentrations than cows fed the medium and high UIP supplements, but cows fed the high UIP supplement had greater (P = .01) insulin levels than the medium treatment animals during gestation periods. In addition, cow body weight was increased by protein supplementation and reproductive performance was unaffected (Sletmoen-Olson et al., 1999) .
These data are interpreted to indicate that blood insulin concentration may be proportional to protein intake, especially during the last trimester of gestation. Bassett et al. (1971) suggested that the quantity of protein that is digested in the small intestine was a causal factor in determining plasma insulin concentration. In our study, dietary CP increased only because supplemental UIP increased. Perhaps increasing the level of UIP supplement increases circulating insulin levels during gestation in forage-fed beef cows. Protein supplementation is typically associated with elevated serum insulin (Krysl et al., 1987; Caton et al., 1988 Caton et al., , 1994 Cheema et al., 1991) . However, the significance of increased blood insulin in ruminants is unclear. Lobley (1992) suggested that the range of concentrations over which insulin exerts anabolic effects in ruminants may Contrast P-value for treatment effects within period protected by significant F-test. 1 = control vs low, medium, and high; 2 = low vs medium and high, 3 = medium vs high; NS = nonsignificant. c P = probability of F-test for period effect within treatment. Contrast P-value for treatment effects within period protected by significant F-test. 1 = control vs low, medium, and high; 2 = low vs medium and high, 3 = medium vs high; NS = nonsignificant. c P = probability of F-test for period effect within treatment. Contrast P-value for treatment effects within period protected by significant F-test. 1 = control vs low, medium, and high; 2 = low vs medium and high, 3 = medium vs high; NS = nonsignificant. c P = probability of F-test for period effect within treatment. be relatively narrow. Apparently, normal protein anabolism may occur at a circulating insulin concentration at or below 25 mU/L.
Insulin concentrations decreased quadratically (P = .01 to .08) as calving approached in cows fed control, low, or medium UIP supplements. During lactation, plasma insulin concentration in protein-supplemented cows during the second month seemed to be depressed relative to mo 1 and 3 (quadratic; P ≤ .06). Curiously, serum insulin did not seem to correspond to patterns in total OM intake during gestation or lactation (Sletmoen-Olson et al., 2000) . In contrast, Bassett et al. (1971) determined that concentration of plasma insulin was positively correlated with digestible OM intake. Insulin concentration was greater in all treatments (P = .01) during gestation than during lactation.
Plasma GH concentration was greater (P ≤ .03) in control cows than in supplemented cows during a majority of the experiment (except mo 7 of gestation; Table  3 ). Similar responses to protein supplementation have been reported in some cases (Krysl et al., 1987; Caton et al., 1988; Cheema et al., 1991; Barton et al., 1992) , but not in others (Branine et al., 1985; Bachman et al., 1989; Caton et al., 1994) . During the 3rd mo of lactation, cows fed the low UIP supplement had higher (P = .01) plasma GH than did medium or high UIP-supplemented cows. Plasma GH in supplemented cows decreased (P ≤ .08) linearly during gestation. Most species do not exhibit a change in GH concentration during pregnancy (Hafez, 1974) . Notably, in our study, only control (unsupplemented) cows had relatively constant GH concentrations during gestation. Bassett et al. (1971) determined that concentration of plasma GH was negatively correlated with insulin concentration and the amount of OM digested in the alimentary tract. They concluded that the metabolic deposition of absorbed nutrients is hormonally regulated in sheep; however, it could have been changes in OM digestibility that altered hormonal profiles.
During lactation, plasma GH increased linearly (P ≤ .09) for the control, low UIP, and medium UIP treatments. Slopes associated with the linear increases in GH for each supplemental treatment seemed to differ, resulting in differences among supplements during mo 3 of lactation. Plasma GH concentration was similar (P > .10) between gestation and lactation for all cows except those on the high UIP treatment, in which plasma GH was lower (P = .05) during lactation than during gestation.
Nutritional status and plasma GH concentration are highly correlated (Tucker, 1985) . Growth hormone is one of several factors that act to increase amino acid uptake by the liver, a process essential to tissue accretion (Hafez, 1974; Martin, 1985) . According to Tucker (1985) , plane of nutrition dramatically affects GH secretion. Typically, GH secretion decreases as nutrient intake increases. The trend for supplemented cows in this study to have lower GH levels than unsupplemented cows supports this concept. Around parturition particularly, control cows were on a lower plane of nutrition than supplemented cows, and plasma GH concentrations reflect this difference. Contrast P-value for treatment effects within period protected by significant F-test. 1 = control vs low, medium, and high; 2 = low vs medium and high, 3 = medium vs high; NS = nonsignificant. c P = probability of F-test for period effect within treatment. Plasma urea N (PUN) concentration was lower (P = .01) in unsupplemented than in supplemented cows (Table 4) . Furthermore, PUN increased (P = .01) with Contrast P-value for treatment effects within period protected by significant F-test. 1 = control vs low, medium, and high; 2 = low vs medium, and high, 3 = medium vs high; NS = nonsignificant. c P = probability of F-test for period effect within treatment. each addition of supplemental UIP to cow diets during both gestation and lactation. Similarly, Caton et al. (1994) also found that PUN increased in steers as UIP was added to the diet. Apparently, PUN concentration in beef cows is proportional to N intake. The concomitant increase in UIP and PUN in our study likely resulted from induction of deaminase activity by excess dietary UIP (Cheema et al., 1991; Barton et al., 1992; Rusche et al., 1993) . Plasma urea N increased quadratically (P = .01) in all treatments to advancing gestation. During lactation, PUN decreased linearly (P ≤ .05) in all treatments. Perhaps as milk production increased, the demand for PUN recycled to the rumen increased. Alternatively, deaminase may have decreased in response to greater demand for α-amino N by the animal during lactation. Plasma urea N was lower (P = .01) during gestation than during lactation. In our study, PUN seems to have merit as an indicator of protein intake; however, PUN does not seem to be a reliable indicator of animal performance or supplement efficacy. Cow body weights, cow body condition scores, cow reproductive performance, and calf performance in the present study were not greatly altered in response to level of UIP (Sletmoen-Olson et al., 2000) .
Plasma NEFA concentration was higher (P ≤ .03) in control cows than in UIP-supplemented cows during all collection periods, except the 1st-mo of lactation (Table  5) . Low UIP-supplemented cows had elevated NEFA (P = .04) during the 9th mo of gestation compared with medium and high UIP-supplemented cows. Plasma NEFA is negatively correlated with energy balance (Erfle et al., 1974) ; moreover, increases in plasma NEFA concentration indicate body fat mobilization (Blauwiekel and Kincaid, 1986) . Plasma NEFA concentration seemed to reflect nutritional status of forage-fed beef cows in our study. Cows on control and low UIP treatments exhibited a linear increase (P ≤ .03) in plasma NEFA during gestation. The general increase in NEFA level that occurred during gestation was expected. Cows were likely meeting energy requirements through adipose mobilization, and this response seemed more pronounced in control and low UIP-supplemented cows than in medium and high UIP-supplemented cows.
In general, NEFA decreased linearly (P = .01) during the first 75 d of lactation. In lactating cows, serum NEFA is reportedly highest immediately postpartum (Blauwiekel and Kincaid, 1986) . In our study, control cows had higher (P = .01) plasma NEFA during gestation than during lactation; however, plasma NEFA in protein-supplemented groups was not different between late gestation and early lactation.
Little research with ruminants has examined plasma NEFA levels in relation to supplemental protein supply. Caton et al. (1988) reported that supplementation of low-quality forage with cottonseed meal did not affect serum NEFA levels. Similarly, when steers were fed three levels of a blood meal-based UIP supplement, NEFA were not different from those of unsupplemented controls (Caton et al., 1994) . Rusche et al. (1993) reported that DIP and UIP supplements had similar effects on plasma NEFA concentration in beef cows; however, others reported that NEFA concentration increased in unsupplemented controls compared with cottonseed meal-supplemented cattle or sheep (Krysl et al., 1987; Cheema et al., 1991; Barton et al., 1992) .
Implications
Protein supplementation can influence plasma concentrations of hormones and metabolites in gestating and lactating beef cows consuming low-quality hay. Increasing undegraded intake protein, after meeting degraded intake protein demands, also affects hormone and metabolite concentration, but to lesser degree than total protein supplied. Nutritional stresses associated with late pregnancy and early lactation were highlighted by increased growth hormone and nonesterified fatty acids and decreased plasma concentrations of insulin. These data imply that gestating and lactating beef cows consuming low-quality hay respond metabolically to both degraded and undegraded intake protein supplementation. Observed changes in hormones and metabolites in response to protein supplementation did not result in altered reproductive performance.
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